| Retrospective Analysis of Extranodal Involvement of Head and Neck Diffuse Large B Cell Lymphomas and Comparison of Nodal Disease | Hakkı KIRKIZLAR,Tuğcan ALP KIRKIZLAR,Ufuk DEMİRCİ,Sedanur KARAMAN GÜLSARAN,Volkan BAŞ,Elif ÜMİT,Ahmet DEMİR | 21–26 |
| Comparison of Prognostic Scoring Systems in Diffuse Large B Cell Lymphoma | Eda ULUSOY,Nergiz ERKUT,ÖZLEN BEKTAŞ,Bircan SÖNMEZ,Mehmet SÖNMEZ | 27–33 |
| Evaluation of the Effects of Prognostic Factors on Clinical Findings and Survival in Patients With a Diagnosis of Chronic Lymphocytic Leukemia | Emel İŞLEYEN,Sema KARAKUŞ,Feride İffet ŞAHİN,Zerrin YILMAZ ÇELİK | 34–43 |
| Pretransplant Elevated Serum D-Dimer Level May Be A Prognostic Marker For Survival in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation | Neslihan MANDACI ŞANLI,Mehmet EMEKLİOĞLU,MUZAFFER KEKLİK,Ali ÜNAL | 44–51 |
| A Flare of Post-ET Myelofibrosis Findings After Ruxolitinib Discontinuation: An Entity to be Recognized | Ufuk DEMİRCİ,Sedanur KARAMAN GÜLSARAN,Volkan BAŞ,Elif ÜMİT,Hakkı KIRKIZLAR,Ahmet DEMİR | 52–55 |